Treatment Selection in Rheumatoid Arthritis
The End of Winter or a False Spring? Introduction of Biosimilars in a Rheumatology Practice
Key Considerations for Using Biosimilars in IBD
Expert Answers to Clinician Questions About Biosimilars
Biosimilars: Addressing Uncertainties With a New Drug Class
Conference CoverageEducationClinical ThoughtDecision SupportCCO Live EventsSlidesets
Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
Clinical Care Options, LLC. All Rights Reserved.